Efficacy and Safety of Oral Immunotherapy With GcMAF in Hospitalized Patients With COVID-19 Pneumonia
Clinical trial NCT04845971 · COMPLETED
Trial details
- NCT number
- NCT04845971
- Sponsor
- Dr. Spadera Lucrezia
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-05
- Primary completion
- 2021-04-30
- Enrollment
- 97
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.